Patents by Inventor Jeremy Clinton Wilt

Jeremy Clinton Wilt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID STATE FORMS OF SUBSTITUTED PYRAZOLOPYRIMIDINES AND USES THEREOF
    Publication number: 20240034738
    Abstract: The present disclosure relates to: a) solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III); b) pharmaceutical compositions comprising one or more solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III), and optionally, a pharmaceutically acceptable carrier or diluent; c) methods of treating tumors or cancers by administering one or more solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III) to a subject in need thereof; and d) methods for the preparation of solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III).
    Type: Application
    Filed: June 14, 2023
    Publication date: February 1, 2024
    Inventors: Hanlan LIU, Jeremy Clinton WILT, Friedrich BLATTER, Giuseppe LAPADULA
  • Solid state forms of substituted pyrazolopyrimidines and uses thereof
    Patent number: 11718624
    Abstract: The present disclosure relates to: a) solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III); b) pharmaceutical compositions comprising one or more solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III), and optionally, a pharmaceutically acceptable carrier or diluent; c) methods of treating tumors or cancers by administering one or more solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III) to a subject in need thereof; and d) methods for the preparation of solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III).
    Type: Grant
    Filed: October 28, 2021
    Date of Patent: August 8, 2023
    Assignee: KSQ Therapeutics, Inc.
    Inventors: Hanlan Liu, Jeremy Clinton Wilt, Friedrich Blatter, Giuseppe Lapadula
  • SOLID STATE FORMS OF SUBSTITUTED PYRAZOLOPYRIMIDINES AND USES THEREOF
    Publication number: 20220162213
    Abstract: The present disclosure relates to: a) solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III); b) pharmaceutical compositions comprising one or more solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III), and optionally, a pharmaceutically acceptable carrier or diluent; c) methods of treating tumors or cancers by administering one or more solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III) to a subject in need thereof; and d) methods for the preparation of solid state forms of a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III).
    Type: Application
    Filed: October 28, 2021
    Publication date: May 26, 2022
    Inventors: Hanlan LIU, Jeremy Clinton WILT, Friedrich BLATTER, Giuseppe LAPADULA
  • PROCESS FOR DRYING BENDAMUSTINE HYDROCHLORIDE MONOHYDRATE
    Publication number: 20160194289
    Abstract: Wet bendamustine hydrochloride monohydrate may be dried by a two stage process wherein rapid drying is first carried out to provide a partially dried product, which is then further dried using an inert gas of controlled relative humidity to yield dry bendamustine hydrochloride monohydrate.
    Type: Application
    Filed: March 16, 2016
    Publication date: July 7, 2016
    Applicant: Johnson Matthey Public Limited Company
    Inventors: Xing FU, Jeremy Clinton WILT
  • Process for drying bendamustine hydrochloride monohydrate
    Patent number: 9315469
    Abstract: Wet bendamustine hydrochloride monohydrate may be dried by a two stage process wherein rapid drying is first carried out to provide a partially dried product, which is then further dried using an inert gas of controlled relative humidity to yield dry bendamustine hydrochloride monohydrate.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: April 19, 2016
    Assignee: Johnson Matthey Public Limited Company
    Inventors: Xing Fu, Jeremy Clinton Wilt
  • PROCESS FOR DRYING BENDAMUSTINE HYDROCHLORIDE MONOHYDRATE
    Publication number: 20140275566
    Abstract: Wet bendamustine hydrochloride monohydrate may be dried by a two stage process wherein rapid drying is first carried out to provide a partially dried product, which is then further dried using an inert gas of controlled relative humidity to yield dry bendamustine hydrochloride monohydrate.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: JOHNSON MATTHEY PLC
    Inventors: Xing Fu, Jeremy Clinton Wilt